Serum amyloid P component (SAP) 1 is a normal plasma glycoprotein composed of non-covalently associated subunits arranged with cyclic pentameric symmetry in a disk-like configuration. It is a member of the pentaxin family of proteins, which includes C-reactive protein (CRP), the classical acute phase reactant, and the homologues of CRP and SAP that exist in lower animals (1, 2) . Although its biological function is unknown, there are a number of observations indicating that SAP is likely to be of both physiological and pathophysiological importance. First, there are proteins that closely resemble human SAP in terms of appearance in the electron microscope, subunit composition, and amino acid sequence in the sera of all vertebrates in which they have been sought (3) (4) (5) . Second, a protein that is immunochemically indistinguishable from SAP is a normal integral constituent of the human glomerular basement membrane (6) and of the peripheral microfibrillar mantle of elastic fibers throughout the body (7) . Third, both in man and lower animals SAP is laid down as amyloid P component (AP), a minor but significant constituent of all forms of amyloid deposits (8) with the possible exception of the intracerebral plaques in human Alzheimer's disease and senile dementia (9) .
In addition to the stable evolutionary conservation of structure in SAP of 
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[a]D temp, optical rotation; AP, amyloid P component; BSA, bovine serum albumin; pmax, frequency of infra-red absorption band; C4bp, C4-binding protein; CRP, Creactive protein; cyclic acetal MOBDG, methyl 4,6-O-(1-carboxyethylidene)-fl-D-galactopyranoside; ~i, chemical shifts; Fn, fibronectin; J, coupling constants; NHS, normal human serum; NMR, nuclear magnetic resonance; non-cyclic acetal MOBDG, methyl (4 or 6)-O-[(R,S)-I '-carboxy-1 '-methoxy-ethyl]4~-D-galactopyranoside; PAGE, polyacrylamide gel electrophoresis; p.p.m., parts per million; Rf, spot mobility on t.l.c.; SAP, serum amyloid P component; signal multiplicities: s, singlets; d, doublets; t, triplets; m, multiplets; t.l.c., thin layer chromatography; TMS, tetramethylsilane; Tris-saline-Ca, 0.01 M Tris-buffered 0.138 M NaCI containing 0.002 M CaCI~ and 0.1% wt/vol NaNs at pH 8.0; Tris-saline°EDTA, 0.01 M Tris-buffered 0.138 M NaCI containing 0.01 M EDTA at pH 8.0. different species, these proteins all share the capacity for specific calciumdependent ligand binding. This property was first discovered with respect to agarose (3, 10, 11) although earlier work on a then unidentified plasma glycoprotein (12) , which was later shown to be SAP (13) , had demonstrated its affinity for calcium ions. It was then established that SAP binds to amyloid fibrils in a calcium-dependent interaction that probably underlies the in vivo deposition of AP (14) . Furthermore, in the presence of calcium, aggregated, but not native, human SAP selectively binds fibronectin (Fn) and C4-binding protein (C4bp) from normal human serum (15) . All these interactions are highly specific and it seems likely that ligand binding by SAP participates in its in vivo function. Identification of the chemical nature of the ligand(s) should therefore help to explain the biological role of SAP and may also contribute to structural characterization of the protein itself.
Although it is most improbable that binding of SAP to agarose is itself related to a physiological function of the protein, it has greatly facilitated the isolation and characterization of SAP from man and other animals and provides a model system suitable for chemical studies. Agarose is a linear galactan hydrocolloid derived from marine algae and composed of repeating units of agarobiose (1,3-1inked ~-D-galactopyranose and 1,4-1inked 3,6-anhydro-a-L-galactopyranose) together with trace amounts of sulfate and pyruvate, the latter as the 4,6-pyruvate acetal of/3-D-galactopyranose (16, 17) (Fig. 1 ). There are large differences in the amounts of SAP that bind to beaded agarose gels from different sources (14) , suggesting that the actual ligand for SAP in agarose may be a variable trace constituent of the polysaccharide. We report here that binding of SAP to gels prepared from a range of agaroses of known composition correlates closely with their pyruvate content, but not at all with the amount of sulfate present. Methylation of the carboxylic acid of the pyruvate residues abolishes the binding of SAP. We have therefore synthesized a pyruvate acetal at the 4,6-positions of galactose, the form in which it exists in agarose, and have shown that it inhibits the calcium-dependent binding of SAP to agarose, to amyloid fibrils, to fibronectin, and to C4-binding protein. The availability of this chemically defined low molecular weight ligand should aid further work on SAP.
Materials and Methods

Agarose
Agaroses of known pyruvate and sulfate content derived from Gelidium and Gracilaria species (kindly provided by FMC Corporation, Rockland, ME) were used to prepare a 4% wt/vol gel in 0.01 M Tris-buffered 0.138 M NaCI containing 0.002 M CaCI2 and 0.1% wt/vol NaN3 at pH 8.0 (Tris-saline-Ca). The gels were fragmented into beads by sequential o:Z
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Diazomethane-treated Aga rose
Pyruvate-rich (0.25% wt/wt) agarose beads (4 ml packed volume) were added to 30 ml of an ethereal solution of diazomethane (18) that had been diluted 1:1 vol/voi in methanol, and stirred for 60 rain at room temperature. After removal of the supernatant, the beads were washed with distilled water and then resuspended in Tris-saline-Ca. Control solventtreated beads were mixed with identical volumes of ether/methanol (1:1 vol/vol) alone.
Chemicals
Methyl/3-D-galactopyranoside, methyl pyruvate, sodium pyruvate, and D-galactose were obtained from Sigma Chemical Co. Ltd., Poole, Dorset, England; ion exchange resin (IR 120 H +) and organic solvents from BDH Ltd., Dagenham, Essex, England and 10% palladium on charcoal from Johnson Matthey Chemicals Ltd., Royston, Herts, England.
Chemical Techniques
all-Nuclear magnetic resonance (NMR) spectra were usually measured in CDCI3 with a JNM-FX200 Fourier transform NMR spectrometer (Jeol Ltd., Tokyo, Japan) or a WH-400 spectrometer (Bruker Ltd., Karlsruhe, Federal Republic of Germany) with tetramethyisilane (TMS) as internal standard. Natural-abundance ~SC-NMR spectra were measured in CDC13 with JNM-FX60 or FX200 instruments (Jeol Ltd.) operating at 15 or 50 MHz, respectively. The 1H-NMR spectra are presented as follows: chemical shifts (6) in parts per million (p.p.m.) downfield from TMS; signal multiplicities (s, d, t, m, for singlets, doublets, triplets, muitiplets); signal intensities (e.g. 3H); coupling constants in Hz (e.g. Jl.~ 3,0 Hz); signal assignment (e.g. H-2). For the 'SC-NMR spectra the chemical shift is reported followed, where possible, by the signal assignment.
Optical rotations ([aID temp) were measured in chloroform with an AA-10 polarimeter (Optical Activity Ltd., Huntingdon, Cambridgeshire, England). Infrared spectra were measured (3'm~x recorded in cm -l) with a 597 spectrometer (Perkin Elmer Ltd., Beaconsfield, Bucks, England) on samples smeared on potassium bromide disks.
Column chromatography was carried out on silica gel 230-400 mesh (Merck Kieselgel 9385, BDH Ltd.). For thin layer chromatography (TLC) 0.25-ram films of silica gel (Merck Kieseigel 60 F2s4, BDH Ltd.) were used, and the spots were located with an ethanol 1% sulfuric acid spray reagent. The mobility of the spot relative to the mobility of the solvent front (Rf) was determined (19) . The eluting solvents were dried over molecular sieves 4A (BDH Ltd.).
Synthesis of acetals of Pyruvic Acid Derived from Methyl 13-D-Galactopyranoside
Preparation of starting materials: Methyl pyruvate dimethyl acetal (compound I) was 
Condensation of methyl 2,3-di-O-benzyl-/3-D-galactopyranoside with methyl pyruvate:
Compound II (1 g) was dissolved in compound I (9 ml) at 20°C. The solution was cooled to 0°C and concentrated sulfuric acid (0.1 ml) added with stirring. The solution was maintained at 20°C under reduced pressure (0.1 mm Hg) for 4 h when TLC (40:60 vol/vol petroleum ether) showed several intense spots in the range R l 0.1-0.5 and a little unchanged compound II (R: 0.0). The acid was then neutralized by stirring the solution with an excess of anhydrous sodium hydrogen carbonate (NaHCO3) added in portions during 3 h. Dichloromethane (1 1) was then added and the solution filtered. The filtrate was washed with aqueous NaHCOs and, after drying, evaporated to give a crude residue that was separated by column chromatography on silica gel with toluene, toluene/ethyl acetate (9:2 vol/vol) as an increasingly polar elutant. The major product was methyl 2, 
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Details of the H and C-NMR results may be obtained from the authors.
Saponification of methyl 3-D-galactopyranoside acetals of methyl pyruvate:
The cyclic acetai methyl ester (compound V) (225 mg) was placed in 1.0 M aqueous sodium hydroxide (0.4 ml) at 23 °C for 24 h~ and then the pH adjusted to 7.4 with 1.0 M hydrochloric acid. This solution of the sodium salt of the acetal was used without further characterization. The mixed non-cyclic acetal methyl ester (compound VI) (141 mg) was similarly treated.
Proteins
Isolated pure SAP (21) and Fn (22) were prepared from normal human serum (NHS) and citrated human plasma, respectively, according to established methods. Isolated pure C4bp (23) was the generous gift of Dr. V. Nussenzweig, New York University, New York. Bovine serum albumin (BSA) was obtained from Sigma Chemical Co. Ltd.
Serum
Fresh NHS was obtained by allowing venous blood from laboratory volunteers to clot at room temperature for 2-4 h before centrifugation. In some experiments, serum from a single donor was used, in others different sera were pooled. Acute phase mouse serum was obtained by exsanguination of MRL mice 48 h after subcutaneous injection of 0. 
Antisera
Monospecific antisera to human SAP and Fn, and to mouse and plaice SAP were raised by immunization of sheep and rabbits with the isolated pure proteins (24, 25) .
Assay of SAP and Fn
Specific protein concentrations were measured by electroimmunoassay (26) using standards of the isolated pure proteins.
PAGE
Gradient PAGE analysis of native proteins was performed in 4-30% gradient gels (Pharmacia, Uppsala, Sweden), run exactly according to the manufacturer's instructions (15) .
Immobilized Proteins
Human SAP was coupled to CNBr-activated Sepharose 4B (Pharmacia) (SAP-Sepharose, 10 mg/ml) in pH 9.0 carbonate buffer precisely as described elsewhere (15) . Control BSA-Sepharose beads (10 mg/ml) were prepared as before (15) .
Isolation of Amyloid Fibrils
Fibrils from the spleen of a patient with reactive systemic (AA) amyloidosis were isolated (27) and lyophilized from distilled water.
Binding of SAP to Agarose Beads and to Amyloid Fibrils
Known amounts of agarose beads and, in different experiments, of amyloid fibrils were equilibrated with Tris-saline-Ca and then tested for SAP binding from serum exactly as described elsewhere (14) . Elution with the chemicals under test was attempted using solutions in Tris-saline-Ca. In other experiments these solutions were added to serum before it was offered to either pyruvate-rich agarose beads (0.25% wt/wt) or fibrils. Trissaline-EDTA was used as a control for complete elution or inhibition of binding of SAP.
Binding of Fn and C4bp by Immobilized Human SAP
The experimental procedure for demonstration of binding of Fn and C4bp from NHS by immobilized SAP has been described previously (15) . Solutions in Tris-saline-Ca of the chemicals under test were used to either elute bound Fn and C4bp or to inhibit their uptake. Eiuates in Tris-saline-EDTA from SAP-Sepharose columns were tested by gradient PAGE and by specific electroimmunoassay for Fn.
Results
Amount of SAP Binding to Different Agaroses of Known Composition. The quantity
of SAP from human, mouse, and plaice serum that bound to different agaroses correlated closely with the pyruvate content of the agarose (human, r = 0.92, n --11, P < 0.001; mouse, r = 0.95, n -4, P < 0.01; plaice, r = 0.98, n = 4, P < 0.001; Fig. 2 ). There was no significant correlation between SAP bound and the sulfate content (human, r --0.26, n = 11; mouse, r = 0.73, n = 4; plaice, r = 0.68, n = 4). Very little SAP bound to agarose gels that contained extremely low levels (0.01% wt/wt) of pyruvate.
Effect of Methylation of the Carboxylic Acid Residues in Agarose.
Prior treatment of the agarose beads with diazomethane completely abolished their capacity to bind SAP (Table I ). Treatment of beads by solvents alone had no effect. Fig. 3 a) , the form in which the pyruvate acetal of galactopyranose exists in agarose. In another experiment, a mixed noncyclic methyl pyruvate acetal of methyl /~-D-galactopyranoside was synthesized and partially identified as compound VI on the basis of its IH and 13C-NMR spectra. This was also saponified to give methyl (4 or 6)-O-(1 '-carboxy-1 '-methoxy-ethyl)-/3-I)-galactopyranoside (the non-cylic acetal MO/3DG; Fig. 3b ). The solutions of these acetals were then corrected to pH 7.4. In the subsequent binding experiments, these solutions were used either in this form or further diluted in Tris-saline-Ca.
Synthesis of Pyruvate Acetals of Methyl 13-o-Galactopyranoside. Methyl 4,6-0-(1-
Inhibition of SAP Binding to Agarose by Synthesized Galactosides. Binding of human, mouse and plaice (Table II) SAP to pyruvate-rich agarose was inhibited by the presence of MO/3DG. The R isomer of the cyclic acetal MO/3DG was more potent than the non-cyclic MO/3DG. For all further experiments with human SAP the R isomer of the cyclic acetal MO/3DG was therefore used. Methyl /~-D-galactopyranoside, pyruvic acid, and D-galactose, all at concentrations of 1-2 × 10 -2 M, had no appreciable effect on the binding of human, mouse, or plaice SAP.
Elution of SAP from Agarose by Synthesized Galactosides. MO/3DG eluted human, mouse, and plaice (Table III) galactose, all at 1-2 × 10 -2 M, did not elute human, mouse, or plaice SAP that had already bound to agarose.
Effect of the Cyclic acetal MOI3DG on Binding of Fn and C4bp by saP-Sepharose.
When added to fresh NHS before mixing with SAP-Sepharose, the R isomer of the cyclic acetal MO/3DG inhibited the binding of both Fn and C4bp. This was shown by immunoassay of Fn (Table IV) and gradient PAGE analysis of the subsequent Tris-saline-EDTA eluate from the SAP-Sepharose. In other experiments, the R isomer of the cyclic acetal MO/3DG eluted Fn ( Table V) and C4bp that were already bound by SAP-Sepharose, the gradient PAGE profile of these eluates being identical to that of the Tris-saline-EDTA eluates (15) .
Effect of the Cyclic Acetal MOI3DG on Human SAP Binding to Amyloid Fibrils. When increasing amounts of the R isomer of the cyclic acetal MO/3DG were added to NHS before being offered to AA amyloid fibrils, there was a progressive Tris-saline-Ca 45 0 MOflDG, R isomer (7.66 × 10 -s M) 0 0 * NHS was offered to SAP-Sepharose in the presence of MOflDG, or Trissaline-Ca as control, and after washing with Tris-saline-Ca was eluted with Tris-saline-EDTA.
TABLE V
Elution of Fn from SAP-Sepharose by the Cyclic Acetal MO[3DG
MOflDG, R isomer concentration (Table VI) . In other experiments, the R isomer of the cyclic acetal MOflDG eluted human SAP that had already bound to the AA amyloid fibrils (Table VII) . No elution was observed with methyl fl-Dgalactopyranoside, pyruvic acid, or D-galactose at concentrations between 10 -4 and2× 10 -2M.
Discussion
The present results show clearly that the amount of SAP that binds to agarose gels is directly related to their pyruvate content. SAP scarcely binds at all to gels that either have been prepared from pyruvate-free agarose or in which the carboxylic moiety of the pyruvate has been methylated by treatment with Analysis of 1H-NMR spectra of this product showed it to be identical to the R isomer of compound V as reported by Garegg et al. (28) . Subsequent saponification of this material yielded the cyclic acetal of MOIiDG. This product was able both to inhibit binding of human, mouse, and plaice SAP to pyruvate-rich agarose and to elute SAP that was already bound. The effective concentration (10-3-10 -2 M) was comparable to the calculated concentration of pyruvate residues in the pyruvate-rich agarose gel (1.66 × 10 -3 M). The importance of the fixed stereochemistry of the cyclic acetal ring in these binding experiments is emphasized by the lower potency of the non-cyclic MOI3DG. The inherent flexibility of this non-cyclic form (Fig. 3 ) presumably results in a poorer stereoalignment for SAP to bind. Pyruvate or D-galactose alone had no inhibitory effects on SAP binding, nor did methyl/3-D-galactopyranoside. Further work is required to determine which parts of the structure of these acetals of MO/3DG are most important for its recognition by SAP, but the methylation experiments suggest that the carboxyl group of the pyruvate residue may be critical. The binding of SAP to agarose is presumably fortuitous and not in any way directly related to the physiological function of the protein. Binding to amyloid fibrils (14) and the more recently discovered interaction between aggregated SAP and Fn and C4bp (15) are probably of greater physiological and pathophysioiogical importance. It is therefore of considerable interest that millimolar concentrations of the R isomer of the cyclic acetal MOIiDG inhibited all these reactions. The ligands for SAP expressed by autologous proteins apparently share some structural similarity with agarose and with MO/iDG, but the resemblance does not necessarily reside in a carbohydrate moiety, since amyloid fibrils consist exclusively of nonglycosylated polypeptide chains (30) . A possible candidate for the polypeptide structure recognized by SAP is the so-called 13-turn, which is thought to exist in amyloid fibrils at the point where the fibril subunit proteins, whether of AA, AL, prealbumin, or other origin, fold back on themselves to form the anti-parallel/3-pleated sheets that characterize amyloid (31) . The 13-turn forms when there are many glycine residues appropriately distributed among bulky hydrophobic L-amino acids, and it is a 10-atom hydrogen-bonded ring inserted into the polypeptide backbone so that the end peptide moiety has its peptide acyl oxygen directed nearly perpendicular to the plane of the other atoms (32) . This is an exposed position in which it is capable of binding cations, and sequences that form B-turns bind calcium ions with high selectivity over other metallic cations (32) . Amyloid fibrils are known to bind calcium (33) as does elastin, the first protein in which 13-turns were described (32) . It is therefore notable that in man normal elastic fibers throughout the body bear SAP on their surface (7) . Both Fn and C4bp bind calcium ions and it is possible that their structures also contain 13-turns.
The functional significance of the existence throughout vertebrate evolution of a plasma protein equipped under certain circumstances to recognize and bind /3-turns in other proteins and/or the pyruvate acetal of galactose in carbohydrates of autologous or extrinsic origin remains obscure. However, identification of MO/3DG as a low molecular weight ligand for SAP should assist investigation of this question. Furthermore the complete amino acid sequences of both human (34) and mouse SAP (35) have recently been elucidated and it should be possible to use MOI3DG to localize the binding sequence in SAP.
SUITlmary
Serum amyloid P component (SAP) is a normal plasma protein that is of interest because of its presence in amyloid deposits, its presence in normal human glomerular basement membrane, and its stable evolutionary conservation. It has calcium-dependent ligand-binding specificity for amyloid fibrils, fibronectin (Fn), C4-binding protein (C4bp), and agarose. Although the binding to agarose, a linear galactan hydrocolloid derived from some marine algae, is unlikely per se to be related to the physiological function of SAP, it does provide a model system in which to explore the precise ligand requirements of SAP. We report here that the amount of SAP from human, mouse, and plaice (Pleuronectes platessa L.) serum able to bind to agarose from different sources reflect precisely their pyruvate content. Methylation with diazomethane of the carboxyl groups in the pyruvate moiety of agarose completely abolishes SAP binding to agarose.
The pyruvate in agarose exists as the 4,6-pyruvate acetal of 13-D-galactopyranose. We have therefore synthesized this galactoside, using a novel procedure, established its structure by analysis of its nuclear magnetic resonance spectra, and shown that it completely inhibits all known calcium-dependent binding reactions of SAP. The R isomer of the cyclic acetal, methyl 4,6-O-(1-carboxyethylidene)-13-D-gaiactopyranoside (MOI3DG) was effective at millimolar concentration and was more potent than its noncyclic analogue, while pyruvate, Dgalactose, and methyl/3-D-galactopyranoside were without effect.
The autologous protein ligands of SAP presumably, therefore express a structural determinant(s) that stereochemically resembles MOI3DG. Availability of this specific, well-characterized, low molecular weight ligand for SAP should facilitate further investigation of the function of SAP and its role in physiological
